We divided the pancreatic cancer patients into two groups: NEK7-negative group (NEK7 positive cancer cells < 5%; n = 48, Figure 6B) and NEK7-positive group (NEK7 positive cancer cells ≥ 5%; n = 42, Figure 6C). This evidence concerns the gene NEK7 and familial pancreatic carcinoma.